CAS 2313526-86-0

Formel: C21H19F3N4O4

InChl: InChI=1S/C21H19F3N4O4/c1-30-19-8-14(4-7-18(19)31-10-13-2-3-13)20(29)27-16-9-15(32-21(22,23)24)5-6-17(16)28-12-25-11-26-28/h4-9,11-13H,2-3,10H2,1H3,(H,27,29)

InChI Key: IQNLJJLZIVCGFI-UHFFFAOYSA-N

SMILES: COC1=C(C=CC(=C1)C(=O)NC2=C(C=CC(=C2)OC(F)(F)F)N3C=NC=N3)OCC4CC4

N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-Methoxybenzamide

CAS: 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-Methoxybenzamide

Formel: C₂₁H₁₉F₃N₄O₄

Reinheit: 98%

Molekulargewicht: 448.4

Ref: 54-PC108428

VU6012962

CAS: 2313526-86-0

VU6012962

Formel: C₂₁H₁₉F₃N₄O₄

Reinheit: 99.5%

Molekulargewicht: 448.4

Ref: 54-BUP12600

VU6012962

CAS: 2313526-86-0

Formel: C₂₁H₁₉F₃N₄O₄

Reinheit: 98.95%

Molekulargewicht: 448.3952

Ref: IN-DA01KL03

VU6012962

CAS: 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide

Formel: C₂₁H₁₉F₃N₄O₄

Reinheit: 98%

Molekulargewicht: 448.4

Ref: IN-DG01100275

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide

CAS: 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally bioavailable and to have an effect on the spinal cord. This drug is effective in doses ranging from 1 mg/kg to 10 mg/kg. N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is still in preclinical stages and has not been tested on humans yet.

Formel: C₂₁H₁₉F₃N₄O₄

Reinheit: Min. 95%

Molekulargewicht: 448.4 g/mol

Ref: 3D-NSD52686

VU6012962

CAS: 2313526-86-0

VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).

Formel: C₂₁H₁₉F₃N₄O₄

Reinheit: 99.61% - 99.74%

Farbe und Form: Solid

Molekulargewicht: 448.3952

Ref: TM-T13323